Header Logo

Connection

Philip Liebson to Ramipril

Back to Details
This is a "connection" page, showing publications Philip Liebson has written about Ramipril.
Philip Liebson
Connection Strength
0.328
Ramipril
  1. Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
    View in: PubMed
    Score: 0.328
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.